Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG-Fresenius S vs. Thymoglobulin in High-Risk Renal Transplant
NCT00861536Phase 4Completed
- Sponsor
- University Hospital Basel
- Start
- Jan 2009
- Primary completion
- Feb 2015
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of antithymocyte globulin rabbit in kidney transplant, sponsored by University Hospital Basel. Started Jan 2009; status: completed.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NCT00861536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00861536.